Holding
Amgen Inc.AMGN
Leading biotech with $186B market cap, 71% gross margin, and 8.6% revenue growth. Equal-weighted at 5%; established biologics portfolio supports strong free cash flow generation.
weight · 5.00%·sector · Healthcare
SPY+0.48%QQQ+0.51%NVDA+0.03%MSFT−0.66%AAPL−1.45%GOOGL+1.11%META+0.50%AMZN−2.09%TSLA−0.54%AVGO−1.16%SPY+0.48%QQQ+0.51%NVDA+0.03%MSFT−0.66%AAPL−1.45%GOOGL+1.11%META+0.50%AMZN−2.09%TSLA−0.54%AVGO−1.16%
